Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation
収録刊行物
-
- Clin Cancer Res
-
Clin Cancer Res 16 5260-5268, 2010